Evidence map›Paper›PMID 34422267›Full record

ArticleTherapeutic advances in infectious disease

Prevalence of

Richard Kwizera, Felix Bongomin, Ronald Olum, William Worodria, Freddie Bwanga, David B Meya, Bruce J Kirenga, Robin Gore, Stephen J Fowler, David W Denning

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Richard KwizeraDepartment of Research, Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O. BOX 22418, Kampala, Central, Uganda,Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0002-5270-3539
Felix BongominDepartment of Medical Microbiology, Faculty of Medicine, Gulu University, Gulu, Uganda, Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0003-4515-8517
Ronald OlumDepartment of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0003-1289-0111
William WorodriaDepartment of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda, Division of Pulmonology, Mulago National Referral Hospital, Kampala, Uganda.
Freddie BwangaDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University Kampala, Uganda.
David B MeyaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda, Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Bruce J KirengaMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda, Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda, Division of Pulmonology, Mulago National Referral Hospital, Kampala, Uganda.
Robin GoreCambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.
Stephen J FowlerDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, UK.
David W DenningDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, UK.
Infectious Diseases Institute · UGMakerere University · UGMulago Hospital · UGUniversity of Manchester · GBCambridge University Hospitals NHS Foundation Trust · GBGulu University · UG

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundSkin prick testing (SPT) is an important investigation in the evaluation of allergy to fungal pathogens. However, the background sensitivity to fungal allergens among healthy people in Uganda is unknown. Our aim was to assess the background prevalence of

methodsFor this pilot study, we recruited 50 healthy volunteers using convenience sampling, 56% of whom were health workers. We performed the SPT for

resultsThe prevalence of

conclusionThere is a high skin positivity against

Indexed as

Aspergillus sensitisationatopyfungal allergyskin prick testingUganda

Identifiers

PMID34422267
PMCPMC8371732
OpenAlexW3194923683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.